Silo Pharma, Inc. (SILO) SEC Filings — 2025
19 SEC filings for Silo Pharma, Inc. (SILO) in 2025.
Filings
- Silo Pharma Faces Delisting Notice — 8-K · Dec 29, 2025
- Silo Pharma's R&D Soars 43% Amidst Widening Losses — 10-Q · Nov 13, 2025
- Silo Pharma Registers 3.07M Shares for Resale, Eyes $2.38M from Warrants — S-1 · Oct 29, 2025
- Silo Pharma Files 8-K: Director Changes, Officer Appointments — 8-K · Oct 24, 2025
- Silo Pharma, Inc. Files 8-K: Material Agreement, Equity Sales — 8-K · Oct 1, 2025
- Silo Pharma Proposes Reverse Stock Split, Board Elections at Annual Meeting — DEF 14A · Sep 5, 2025
- Silo Pharma's R&D Spend Soars 69% Amid Widening Losses — 10-Q · Aug 13, 2025
- Silo Pharma Files 8-K — 8-K · Aug 5, 2025
- Silo Pharma, Inc. Files 8-K: Material Agreement & Equity Sales — 8-K · Jul 29, 2025
- Silo Pharma Enters Material Definitive Agreement — 8-K · Jul 10, 2025
- Silo Pharma Faces Delisting Concerns — 8-K · Jul 3, 2025
- Silo Pharma Enters Material Definitive Agreement — 8-K · May 16, 2025
- Silo Pharma Files S-1/A Amendment — S-1/A · May 9, 2025
- Silo Pharma Files S-1/A Amendment — S-1/A · Apr 29, 2025
- Silo Pharma Files S-1 Registration Statement — S-1 · Apr 25, 2025
- Silo Pharma Files 2024 Annual Report — 10-K · Mar 28, 2025
- Silo Pharma Files 8-K: Regulation FD Disclosure & Other Events — 8-K · Mar 10, 2025
- Silo Pharma Files 8-K — 8-K · Mar 7, 2025
- Silo Pharma Files 8-K Report — 8-K · Jan 2, 2025